The website of Pathology In Practice Magazine

Flow cytometry data analysis system launched

Beckman Coulter has launched the Kaluza C flow cytometry analysis software, an advanced data analysis system for the clinical laboratory. The new software streamlines clinical quality control (QC) reporting and addresses standardisation issues in flow cytometry. Kaluza C is CE-marked and listed with the US Food and Drug administration (FDA). It builds on the company’s existing Kaluza analysis software, which is already an essential analysis tool for life science researchers.

Kaluza C software improves the visualisation and analysis of rare events.  It makes it possible to process large, multicolour files with up to 20 million events, and set the plot resolution according to the gate level.  Furthermore, it enables the operator to focus on a limited number of events to preserve the integrity of the scatter plot.   Tools such as easy Boolean gate formation and autogating are also incorporated to improve the analysis of complex data sets. 

www.beckman.com

Upcoming Events

Every Minute Counts: a SHOT, BBTS and NBTC joint webinar

Online
3 December 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Every Minute Counts: a SHOT, BBTS and NBTC joint webinar

Online
3 December 2021

IBMS Biomedical Science Congress 2022

International Convention Centre, Birmingham
14-17 March 2022

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2021 Step Communications Ltd. Registered in England. Registration Number 3893025